First Time Loading...

C4 Therapeutics Inc
NASDAQ:CCCC

Watchlist Manager
C4 Therapeutics Inc Logo
C4 Therapeutics Inc
NASDAQ:CCCC
Watchlist
Price: 6.74 USD 4.82% Market Closed
Updated: May 5, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

376.5m
+13%
Assets
Growth Rates:
1 Year
-13%
3 Years
-6%
5 Years
-
7 Years
-
10 Years
-
130.3m
+11%
Liabilities
Growth Rates:
1 Year
-8%
3 Years
+9%
5 Years
-
7 Years
-
10 Years
-
246.1m
+14%
Equity
Growth Rates:
1 Year
-15%
3 Years
-12%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
C4 Therapeutics Inc

376.5m
Assets
130.3m
Liabilities
376.5m
Assets
130.3m
Liabilities
Current Assets 271.2m
Cash & Short-Term Investments 253.7m
Receivables 11.8m
Other Current Assets 5.7m
Non-Current Assets 105.3m
Long-Term Investments 28m
PP&E 71.1m
Other Non-Current Assets 6.2m
Current Liabilities 42.8m
Accounts Payable 1.4m
Accrued Liabilities 23.8m
Other Current Liabilities 17.5m
Non-Current Liabilities 87.6m
Other Non-Current Liabilities 87.6m

Balance Sheet
C4 Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
36
91
182
76
30
127
Cash Equivalents
36
91
182
76
30
127
Short-Term Investments
0
0
190
233
246
127
Total Receivables
86
5
5
6
2
12
Accounts Receivables
86
5
5
6
2
12
Other Receivables
0
0
0
0
0
0
Other Current Assets
1
2
5
11
10
6
Total Current Assets
124
97
381
326
288
271
PP&E Net
20
19
17
35
78
71
PP&E Gross
20
19
17
35
78
71
Accumulated Depreciation
3
4
6
7
8
8
Long-Term Investments
0
0
0
142
61
28
Other Long-Term Assets
3
3
3
4
5
6
Total Assets
147
N/A
118
-19%
400
+238%
507
+27%
431
-15%
376
-13%
Liabilities
Accounts Payable
1
5
6
5
1
1
Accrued Liabilities
3
7
10
15
22
24
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
2
0
Other Current Liabilities
20
21
28
32
19
18
Total Current Liabilities
24
34
44
51
45
43
Long-Term Debt
0
0
10
11
9
0
Other Liabilities
91
86
65
55
88
88
Total Liabilities
115
N/A
119
+3%
119
+0%
117
-2%
142
+21%
130
-8%
Equity
Common Stock
111
111
0
0
0
0
Retained Earnings
83
118
184
268
396
528
Additional Paid In Capital
4
6
465
658
689
775
Other Equity
0
0
0
1
4
0
Total Equity
31
N/A
1
N/A
281
N/A
390
+39%
289
-26%
246
-15%
Total Liabilities & Equity
147
N/A
118
-19%
400
+238%
507
+27%
431
-15%
376
-13%
Shares Outstanding
Common Shares Outstanding
42
42
43
49
49
60

See Also

Summary
CCCC intrinsic value, competitors valuation, and company profile.
DCF Valuation
CCCC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CCCC stock valuation using valuation multiples.
Wall Street Estimates
CCCC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CCCC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.